Last reviewed: December 27, 2021 On this page: Overview Efficacy vs. Omicron Bamlanivimab/Etesevimab Casirivimab/Imdevimab Sotrovimab Tixagevimab/Cilgavimab Guidelines Key Literature Resources Multimedia Overview Monoclonal antibodies are a type of therapeutic agent under investigation for the treatment of COVID-19. These agents are often created by identifying…
Buddy Creech, MD, MPH, FPIDS, and Febrile creator and infectious diseases physician, Sara Dong, MD, discuss the power of digital education tools on infectious diseases…
Researchers used public health datasets to train machine learning models to predict HIV incidence with high accuracy.
Researchers used public health datasets to train machine learning models to predict HIV incidence with high accuracy.
The call for officer and director applications for the IDSA Board of Directors is now open. We are seeking volunteers for the office of Vice…
With regular posts, IDSA’s and HIVMA’s blog reminds readers that infectious diseases don’ t observe national borders, and effective, evidence-based responses protect us all. With…
HIVMA Board member Joseph Cherabie, MD, MSc (@JncherabieMD), provides a front-line perspective on the surge in syphilis cases and shares practical tips for clinicians.
IDSA and HIVMA are disappointed and alarmed that Uganda’s Constitutional Court upheld the Anti-Homosexuality Act criminalizing LGBTQ individuals and their right to organize, educate and…
HIVMA Board member Joseph Cherabie, MD, MSc (@JncherabieMD), provides a front-line perspective on the surge in syphilis cases and shares practical tips for clinicians.
Clinical Practice Innovation Award; D.A. Henderson Award for Outstanding Contributions to Public Health; Alexander Fleming Award for Lifetime Achievement; The Watanakunakorn Clinician Award; The Walter…
